Epithelial barrier defects have been demonstrated in asthma, AD and chronic rhinosinusitis for genetic reasons, epithelial barrier toxic substances and immune system cells and cytokines involved in the type 2 response, mainly IL-4 and IL-13 [9–12]. This evidence concerns the gene IL13 and asthma.